Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System

February 20, 2020 updated by: Zimmer Biomet

A Prospective Multicenter Lumbar Spine Fusion Study to Evaluate the Effectiveness of the Biomet Lumbar Spinal Fusion System

The purpose of this study is to evaluate the effectiveness of the Biomet Lumbar Spinal Fusion System in patients undergoing lumbar fusion surgery.

Study Overview

Status

Completed

Detailed Description

All subjects enrolled in this study will receive the The Biomet Osteobiologic Treatment System which is comprised of the SpF® Spine Fusion Stimulator and any or all of the following can be utilized in the study: any Pedicle Screw System, autograft and an Interbody Spacer

Study Type

Observational

Enrollment (Actual)

53

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Terre Haute, Indiana, United States, 47807
        • Union Hospital Neurosurgical
    • Michigan
      • Flint, Michigan, United States, 48507
        • Family Orthopedic Associates
    • Ohio
      • Columbus, Ohio, United States, 43212
        • Orthopedics and Neurological Consultants, Inc
    • Wisconsin
      • Waukesha, Wisconsin, United States, 53188
        • Neurological Associates of Waukesha

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This study is open to all patients with one or two level Degenerative Disease who are between the ages of 18 and 75.

Description

Inclusion Criteria:

  1. The subject must, in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent.
  2. The subject must be diagnosed with degenerative disc disease at up to 2 levels from L2-S1 inclusive and undergoing up to 2 level posterior lumbar spinal fusion surgery with or without anterior column fusion.
  3. Subjects must be between 18 and 75 years of age.
  4. The patient must be skeletally mature (epiphyses closed).

Exclusion Criteria:

  1. Subject is pregnant, lactating or interested in becoming pregnant during the duration of the study.
  2. Any active litigation.
  3. Subject is currently involved in another investigational study.
  4. Subject has a history (present or past) of substance abuse (recreational drugs, prescription drugs or alcohol) that in the investigator's opinion may interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up.
  5. Subject is incarcerated.
  6. More than 2 prior spine surgeries/revision surgeries or any previous spinal fusions at levels being currently treated.
  7. Traumatic instability.
  8. Any parathyroid or metabolic bone disease.
  9. Any active malignancy.
  10. Osteopenia/Osteoporosis - All subjects will be screened for osteoporosis using SCORE (Simple Calculated Osteoporosis Risk Estimation) with a threshold value of 6. All subjects with a SCORE value greater than 6 will be referred for Dual-energy X-ray absorptiometry (DEXA) Scan. Subjects with a T-Score of £-1-2.5 will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Radiographic Fusion
Time Frame: 12 Month
12 Month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS) change from baseline
Time Frame: 24 Months
Mean VAS % change from baseline
24 Months
Oswestry Disability Index change from baseline
Time Frame: 24 Month
Oswestry Disability Index % change from baseline
24 Month
Neurologic Assessment, Maintenance or improvement from baseline
Time Frame: 12 Month
12 Month
Short Form Health Survey (SF-36) % change from baseline
Time Frame: 24 Month
24 Month
Time to return to work
Time Frame: 24 month
24 month
Time to return to normal activity
Time Frame: 24 month
24 month
Narcotic Use
Time Frame: 24 month
pre and post-operatively
24 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Joel Batts, Biomet Spine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2008

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

September 9, 2008

First Submitted That Met QC Criteria

September 23, 2008

First Posted (Estimate)

September 25, 2008

Study Record Updates

Last Update Posted (Actual)

February 24, 2020

Last Update Submitted That Met QC Criteria

February 20, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Disc Disease

3
Subscribe